CYP2C8 and cancer: These include older age, presence of cancer and its type, type of bisphosphonate agent and duration of therapy, concomitant osteoporosis or osteopenia with cancer, diabetes, corticosteroid therapy, alcohol and chemotherapeutic agents, and gene polymorphisms including MMP2 and CYP2C8 [17, 18].